212 related articles for article (PubMed ID: 24117117)
1. Correlations between cerebellar and brain volumes, cognitive impairments, ApoE levels, and APOE genotypes in patients with AD and MCI.
Łojkowska W; Witkowski G; Bednarska-Makaruk M; Wehr H; Sienkiewicz-Jarosz H; Graban A; Bochyńska A; Wiśniewska A; Gugała M; Sławińska K; Sawicka B; Poniatowska R; Ryglewicz D
Curr Alzheimer Res; 2013 Nov; 10(9):964-72. PubMed ID: 24117117
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
3. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
4. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
[TBL] [Abstract][Full Text] [Related]
5. Impact of APOE in mild cognitive impairment.
Farlow MR; He Y; Tekin S; Xu J; Lane R; Charles HC
Neurology; 2004 Nov; 63(10):1898-901. PubMed ID: 15557508
[TBL] [Abstract][Full Text] [Related]
6. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
8. APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: A Longitudinal Study.
Camarda C; Torelli P; Pipia C; Sottile G; Cilluffo G; Camarda R
Curr Alzheimer Res; 2020; 17(8):766-780. PubMed ID: 33167837
[TBL] [Abstract][Full Text] [Related]
9. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.
Luckhaus C; Cohnen M; Flüss MO; Jänner M; Grass-Kapanke B; Teipel SJ; Grothe M; Hampel H; Peters O; Kornhuber J; Maier W; Supprian T; Gaebel W; Mödder U; Wittsack HJ
Psychiatry Res; 2010 Jul; 183(1):44-51. PubMed ID: 20541374
[TBL] [Abstract][Full Text] [Related]
10. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan.
Wang PN; Lirng JF; Lin KN; Chang FC; Liu HC
Neurobiol Aging; 2006 Dec; 27(12):1797-806. PubMed ID: 16321457
[TBL] [Abstract][Full Text] [Related]
12. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
13. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
Horvath A; Quinlan P; Eckerström C; Åberg ND; Wallin A; Svensson J
J Alzheimers Dis; 2024; 99(2):609-622. PubMed ID: 38701139
[TBL] [Abstract][Full Text] [Related]
14. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease.
Morgen K; Ramirez A; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S269-76. PubMed ID: 24613704
[TBL] [Abstract][Full Text] [Related]
15. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
[TBL] [Abstract][Full Text] [Related]
18. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
[TBL] [Abstract][Full Text] [Related]
19. Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI).
Ngwa JS; Fungwe TV; Ntekim O; Allard JS; Johnson SM; Castor C; Graham L; Nadarajah S; Gillum RF; Obisesan TO;
Dement Geriatr Cogn Disord; 2018; 45(1-2):66-78. PubMed ID: 29694964
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
